A brief review of the WHO reporting system for pancreaticobiliary cytopathology

• Type: Article in International Scientific Journal
• Date: 2023

Authors

Pitman, B (Author) Other; Centeno, A (Author) Other; Reid, D (Author) Other; Saeig, M (Author) Other; Siddiqui, T (Author) Other; Layfield, J (Author) Other; Perez Machado, M (Author) Other; Weynand, B (Author) Other; Stelow, B (Author) Other; Lozano, D (Author) Other; Fukushima, N (Author) Other; Cree, A (Author) Other; Mehrotra, R (Author) Other; Fernando Schmitt (Author) FMUP; Field, S (Author) Other

Journal

Title: Journal of the American Society of Cytopathology

Vol. 12

Pages: 243-250

ISSN: 2213-2945

Publisher: Elsevier

Indexing

Scopus - 4 Citations

Other information

Authenticus ID: P-00Y-8DV

DOI: 10.1016/j.jasc.2023.03.002

Abstract (EN): The World Health Organization (WHO), the International Academy of Cytology, and the International Agency for Research on Cancer have developed an approach to standardized reporting of pancreaticobiliary cytopathology. The WHO Reporting System for Pancreaticobiliary Cytopathology (WHO System) revises the Papanicolaou Society of Cytopathology (PSC) System for Reporting Pancreaticobiliary Cytology published in 2015 and replaces the 6 PSC categories with 7 categories: ¿Insufficient/Inadequate/Nondiagnostic¿; ¿Benign/Negative for malignancy¿; ¿Atypical¿; ¿Pancreaticobiliary neoplasm, low risk/grade (PaN-low)¿; ¿Pancreatic neoplasm, high risk/grade (PaN-High)¿; ¿Suspicious for malignancy¿; and ¿Malignant¿. In the PSC system, there is a single category for ¿Neoplastic¿ lesions that includes 2 groups, 1 for benign neoplasms and 1 named ¿Neoplastic-other¿, dominated by premalignant intraductal neoplasms primarily intraductal papillary mucinous neoplasms and low-grade malignant neoplasms (pancreatic neuroendocrine tumors (PanNET) and solid pseudopapillary neoplasms (SPN). In the WHO System, benign neoplasms with virtually no risk of malignancy are included in the ¿Benign¿ category and low-grade malignancies (PanNET and SPN) are included in the ¿Malignant¿ category, as per the 5th edition of the WHO Classification of Digestive System Tumors, while the non-invasive pre-malignant lesions of the ducts are divided by the cytomorphological grade of the epithelium into PaN-low and PaN-high with distinctly different risks of malignancy. Within each category, key diagnostic cytopathologic features and the ancillary studies for diagnostic and prognostic evaluation, as well as the implications of diagnosis for patient care and management, are outlined. Reporting and diagnostic management options recognize the variations in the availability of diagnostic and prognostic ancillary testing modalities in low- and middle-income countries. © 2023

Language: English

Type (Professor's evaluation): Scientific